Free Trial

Amphastar Pharmaceuticals (AMPH) SEC Filings & 10K Form

Amphastar Pharmaceuticals logo
$35.68 -0.35 (-0.97%)
As of 09:48 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Amphastar Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/16/2024
4:22 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:28 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
10:37 AM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
7:26 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
7:05 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/12/2024
12:29 PM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
6:02 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:09 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
6:48 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
3:48 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2024
8:33 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:26 PM
Amphastar Pharmaceuticals (Subject)
Zhou Rong (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2024
4:58 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
4:25 PM
Amphastar Pharmaceuticals (Subject)
PRINS RICHARD K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:15 PM
Amphastar Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:22 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
3:32 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
4:24 PM
Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/28/2024
3:26 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2024
3:25 PM
Amphastar Pharmaceuticals (Subject)
PETERS WILLIAM J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2024
5:35 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:32 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:51 PM
Amphastar Pharmaceuticals (Subject)
Petersen Floyd F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2024
7:10 PM
Amphastar Pharmaceuticals (Issuer)
Lee Howard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:54 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:56 PM
Amphastar Pharmaceuticals (Issuer)
Deflin Gayle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:03 PM
Amphastar Pharmaceuticals (Issuer)
Gerst Diane G. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:56 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
4:58 PM
Amphastar Pharmaceuticals (Issuer)
PRINS RICHARD K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
5:00 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
5:26 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:56 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
3:21 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:08 PM
Amphastar Pharmaceuticals (Filer)
Form DEF 14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
04/12/2024
3:14 PM
Amphastar Pharmaceuticals (Filer)
Form DEFA14A
Please take this warning seriously... (Ad)

I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader in the country – in the next 30 days. In fact, I believe it could begin as soon as January 29th… Meaning you don’t have much time to prepare.

Click here like your financial health depends on it.
04/02/2024
8:31 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
5:55 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:47 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:49 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:52 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:32 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:54 PM
Amphastar Pharmaceuticals (Issuer)
Liawatidewi Yakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:57 PM
Amphastar Pharmaceuticals (Issuer)
ZASLOFF MICHAEL A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:29 PM
Amphastar Pharmaceuticals (Issuer)
Luo Mary Z. (Reporting)
Zhang Jack Y. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:49 PM
Amphastar Pharmaceuticals (Issuer)
PETERS WILLIAM J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:51 PM
Amphastar Pharmaceuticals (Issuer)
Zhou Rong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
9:23 AM
Amphastar Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Form SC 13G/A
03/05/2024
12:21 PM
Amphastar Pharmaceuticals (Subject)
ZASLOFF MICHAEL A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/04/2024
7:35 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
3:53 PM
Amphastar Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
3:38 PM
Amphastar Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
4:21 PM
Amphastar Pharmaceuticals (Subject)
Zhang Jack Y. (Filed by)
Form SC 13G/A
02/02/2024
6:37 PM
Amphastar Pharmaceuticals (Issuer)
Petersen Floyd F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
10:53 AM
Amphastar Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AMPH) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners